SIGMA-1 RECEPTOR AS A NOVEL DRUG TARGET IN DIABETES-INDUCED NON-RETINAL OCULAR COMPLICATIONS  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
135398
Type K
Principal investigator Fekete, Andrea
Title in Hungarian A Sigma-1 receptor, mint új gyógyszertámadáspont a diabéteszes szemészeti szövődmények kezelésében
Title in English SIGMA-1 RECEPTOR AS A NOVEL DRUG TARGET IN DIABETES-INDUCED NON-RETINAL OCULAR COMPLICATIONS
Keywords in Hungarian Sigma-1 receptor, diabetes, corneal dysfunction, fibrózis
Keywords in English Sigma-1 receptor, diabetes, corneal dysfunction, fibrosis
Discipline
Endocrinology, diabetes, metabolism, toxicology (Council of Medical and Biological Sciences)40 %
Molecular biology (Council of Medical and Biological Sciences)30 %
Ortelius classification: Molecular markers and recognition
Sensory systems (e.g. visual system, auditory system) (Council of Medical and Biological Sciences)30 %
Panel Physiology, Pathophysiology, Pharmacology and Endocrinology
Department or equivalent 1st Dept. of Pediatrics (Semmelweis University)
Participants Czakó, Cecilia
Farkas, Alexandra
Kis, Judit
Kovács, Illés
Lénárt, Lilla
Szabó, Adrienn
Tóth, Ákos
Starting date 2020-11-01
Closing date 2024-10-31
Funding (in million HUF) 47.640
FTE (full time equivalent) 15.85
state running project




Back »